{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T02:00:23Z","timestamp":1780452023154,"version":"3.54.1"},"reference-count":82,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T00:00:00Z","timestamp":1583452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>Acinetobacter (A.) baumannii has gained global notoriety as a significant nosocomial pathogen because it is frequently associated with multi-drug resistance and hospital-based outbreaks. There is a substantial difference in the incidence of A. baumannii infections between different countries and within Germany. However, its continuous spread within Germany is a matter of concern. A systematic literature search and analysis of the literature published between 2000 and 2018 on A. baumannii in humans was performed. Forty-four studies out of 216 articles met the criteria for inclusion, and were selected and reviewed. The number of published articles is increasing over time gradually. Case reports and outbreak investigations are representing the main body of publications. North Rhine-Westphalia, Hesse and Baden-Wuerttemberg were states with frequent reports. Hospitals in Cologne and Frankfurt were often mentioned as specialized institutions. Multiresistant strains carrying diverse resistance genes were isolated in 13 of the 16 German states. The oxacillinase blaOXA-23-like, intrinsic blaOXA-51-like, blaOXA-58 variant, blaNDM-1, blaGES-11, blaCTX-M and blaTEM are the most predominant resistance traits found in German A. baumannii isolates. Five clonal lineages IC-2, IC-7, IC-1, IC-4 and IC-6 and six sequence types ST22, ST53, ST195, ST218, ST944\/ST78 and ST348\/ST2 have been reported. Due to multidrug resistance, colistin, tigecycline, aminoglycosides, fosfomycin, ceftazidime\/avibactam and ceftolozan\/tazobactam were often reported to be the only effective antibiotics left to treat quadruple multi-resistant Gram-negative (4MRGN) A. baumannii. Dissemination and infection rates of A. baumannii are on the rise nationwide. Hence, several aspects of resistance development and pathogenesis are not fully understood yet. Increased awareness, extensive study of mechanisms of resistance and development of alternative strategies for treatment are required. One-Health genomic surveillance is needed to understand the dynamics of spread, to identify the main reservoirs and routes of transmission and to develop targeted intervention strategies.<\/jats:p>","DOI":"10.3390\/microorganisms8030375","type":"journal-article","created":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T09:26:41Z","timestamp":1583486801000},"page":"375","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Spatio-Temporal Distribution of Acinetobacter baumannii in Germany\u2014A Comprehensive Systematic Review of Studies on Resistance Development in Humans (2000\u20132018)"],"prefix":"10.3390","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6259-1932","authenticated-orcid":false,"given":"Gamal","family":"Wareth","sequence":"first","affiliation":[{"name":"Friedrich-Loeffler-Institut, Institute of Bacterial Infections and Zoonoses, Naumburger Str. 96a, 07743 Jena, Germany"},{"name":"Faculty of Veterinary Medicine, Benha University, Moshtohor, Toukh 13736, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7199-3957","authenticated-orcid":false,"given":"Christian","family":"Brandt","sequence":"additional","affiliation":[{"name":"Institute for Infectious Diseases and Infection Control, Jena University Hospital, Am Klinikum 1, 07747 Jena, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa D.","family":"Sprague","sequence":"additional","affiliation":[{"name":"Friedrich-Loeffler-Institut, Institute of Bacterial Infections and Zoonoses, Naumburger Str. 96a, 07743 Jena, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinrich","family":"Neubauer","sequence":"additional","affiliation":[{"name":"Friedrich-Loeffler-Institut, Institute of Bacterial Infections and Zoonoses, Naumburger Str. 96a, 07743 Jena, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8157-2753","authenticated-orcid":false,"given":"Mathias W.","family":"Pletz","sequence":"additional","affiliation":[{"name":"Institute for Infectious Diseases and Infection Control, Jena University Hospital, Am Klinikum 1, 07747 Jena, Germany"},{"name":"Research Campus Infectognostics, Philosophenweg 7, 07743 Jena, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,3,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"787","DOI":"10.12998\/wjcc.v2.i12.787","article-title":"Antimicrobial resistance in Acinetobacter baumannii: From bench to bedside","volume":"2","author":"Lin","year":"2014","journal-title":"World J. Clin. Cases"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.4161\/viru.19700","article-title":"Acinetobacter baumannii: An emerging opportunistic pathogen","volume":"3","author":"Howard","year":"2012","journal-title":"Virulence"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/2049-632X.12125","article-title":"Acinetobacter baumannii: Evolution of a global pathogen","volume":"71","author":"Antunes","year":"2014","journal-title":"Pathog. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Yakkala, H., Samantarrai, D., Gribskov, M., and Siddavattam, D. (2019). Comparative genome analysis reveals niche-specific genome expansion in Acinetobacter baumannii strains. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0218204"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1055\/s-0034-1398388","article-title":"Acinetobacter baumannii: Evolution of antimicrobial resistance-treatment options","volume":"36","author":"Doi","year":"2015","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1128\/microbiolspec.ARBA-0007-2017","article-title":"Antimicrobial resistance in Acinetobacter spp. and Pseudomonas spp.","volume":"6","author":"Lupo","year":"2018","journal-title":"Microbiol. Spectr."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.bjm.2016.06.005","article-title":"Mobile genetic elements related to carbapenem resistance in Acinetobacter baumannii","volume":"47","author":"Pagano","year":"2016","journal-title":"Braz. J. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000445022","article-title":"Antimicrobial susceptibility among European Gram-negative and Gram-positive isolates collected as part of the Tigecycline Evaluation and Surveillance Trial (2004\u20132014)","volume":"62","author":"Rodloff","year":"2017","journal-title":"Chemotherapy"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1128\/jcm.31.9.2417-2420.1993","article-title":"Epidemiological study of an Acinetobacter baumannii outbreak by using polymerase chain reaction fingerprinting","volume":"31","author":"Graser","year":"1993","journal-title":"J. Clin. Microbiol."},{"key":"ref_10","first-page":"544","article-title":"The distribution of Acinetobacter species in clinical culture materials","volume":"279","author":"Seifert","year":"1993","journal-title":"Zent. Bakteriol. Int. J. Med Microbiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1017\/S0950268800057228","article-title":"Genetic diversity and clonal relationships of Acinetobacter baumannii strains isolated in a neonatal ward: Epidemiological investigations by allozyme, whole-cell protein and antibiotic resistance analysis","volume":"111","author":"Thurm","year":"1993","journal-title":"Epidemiol. Infect."},{"key":"ref_12","first-page":"210","article-title":"The clinical significance of Acinetobacter baumannii in blood cultures","volume":"277","author":"Seifert","year":"1992","journal-title":"Zent. Bakteriol. Int. J. Med Microbiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.ajic.2017.12.014","article-title":"Nosocomial outbreaks caused by Acinetobacter baumannii and Pseudomonas aeruginosa: Results of a systematic review","volume":"46","author":"Wieland","year":"2018","journal-title":"Am. J. Infect. Control"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jhin.2004.04.016","article-title":"Metallo-beta-lactamase expressing multi-resistant Acinetobacter baumannii transmitted in the operation area","volume":"57","author":"Borgmann","year":"2004","journal-title":"J. Hosp. Infect."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1055\/s-0029-1244211","article-title":"Management eines Ausbruchs nosokomialer Pneumonien durch einen neuen multiresistenten Acinetobacter baumannii-Klon","volume":"64","author":"Frickmann","year":"2010","journal-title":"Pneumologie"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1099\/jmm.0.012302-0","article-title":"Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in a German university medical centre","volume":"58","author":"Kohlenberg","year":"2009","journal-title":"J. Med Microbiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1055\/s-0034-1372626","article-title":"Management eines Ausbruches mit 4 MRGN Acinetobacter baumannii in einem Brandverletzten-zentrum","volume":"46","author":"Siemers","year":"2014","journal-title":"Handchir. Mikrochir. Plast. Chir."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13756-018-0436-8","article-title":"One-year molecular surveillance of carbapenem-susceptible A. baumannii on a German intensive care unit: Diversity or clonality","volume":"7","author":"Wendel","year":"2018","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1093\/jac\/dku170","article-title":"Detection of pan drug-resistant Acinetobacter baumannii in Germany","volume":"69","author":"Gottig","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ijantimicag.2014.08.001","article-title":"The bigger picture: The history of antibiotics and antimicrobial resistance displayed by scientometric data","volume":"44","author":"Brandt","year":"2014","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Katchanov, J., Asar, L., Klupp, E.M., Both, A., Rothe, C., Konig, C., Rohde, H., Kluge, S., and Maurer, F.P. (2018). Carbapenem-resistant Gram-negative pathogens in a German university medical center: Prevalence, clinical implications and the role of novel beta-lactam\/beta-lactamase inhibitor combinations. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0195757"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12941-018-0299-0","article-title":"Cerebrospinal fluid penetration of very high-dose meropenem: A case report","volume":"17","author":"Kerz","year":"2018","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s15010-018-1192-7","article-title":"Evaluation of the multiplex PCR based assay Unyvero implant and tissue infection application for pathogen and antibiotic resistance gene detection in children and neonates","volume":"47","author":"Papan","year":"2018","journal-title":"Infection"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1089\/mdr.2017.0141","article-title":"High prevalence of multidrug-resistant bacteria in Libyan War Casualties admitted to a tertiary care hospital, Germany","volume":"24","author":"Lohr","year":"2018","journal-title":"Microb. Drug Resist."},{"key":"ref_25","first-page":"2050313x17711630","article-title":"Therapeutic drug monitoring for colistin therapy in severe multi-resistant Acinetobacter intracerebral abscess: A single case study with high-dose colistin and review of literature","volume":"5","author":"Tafelski","year":"2017","journal-title":"SAGE Open Med Case Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1089\/mdr.2016.0035","article-title":"Molecular investigation of carbapenem-resistant Acinetobacter spp. from hospitals in North Rhine-Westphalia, Germany","volume":"23","author":"Rieber","year":"2017","journal-title":"Microb. Drug Resist."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"30110","DOI":"10.2807\/1560-7917.ES.2016.21.2.30110","article-title":"Multidrug-resistant organisms detected in refugee patients admitted to a University Hospital, Germany June to December 2015","volume":"21","author":"Reinheimer","year":"2016","journal-title":"Eurosurveillance"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1093\/jac\/dkv462","article-title":"Carbapenem-resistant Acinetobacter baumannii ST78 with OXA-72 carbapenemase and ESBL gene blaCTX-M-115","volume":"71","author":"Pfeifer","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_29","first-page":"16","article-title":"Lung transplantation in a multidrug-resistant Gram-negative Acinetobacter baumannii-colonized aatient: A case report","volume":"5","author":"Huenges","year":"2016","journal-title":"Thorac. Cardiovasc. Surg. Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jhin.2015.11.007","article-title":"Outbreak of carbapenem-resistant Acinetobacter baumannii in the intensive care unit: A multi-level strategic management approach","volume":"92","author":"Molter","year":"2016","journal-title":"J. Hosp. Infect."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1128\/JCM.00721-16","article-title":"Whole genome sequencing elucidates epidemiology of nosocomial clusters of Acinetobacter baumannii","volume":"54","author":"Willems","year":"2016","journal-title":"J. Clin. Microbiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12941-016-0120-x","article-title":"MALDI-TOF MS based carbapenemase detection from culture isolates and from positive blood culture vials","volume":"15","author":"Ghebremedhin","year":"2016","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s15010-014-0661-x","article-title":"Multidrug resistant Acinetobacter baumannii reaches a new frontier: Prosthetic hip joint infection","volume":"43","author":"Hischebeth","year":"2015","journal-title":"Infection"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s10072-014-2031-y","article-title":"Full remission in a patient with catheter-associated ventriculitis due to Acinetobacter baumannii treated with intrathecal and intravenous colistin besides coinfections with other multidrug-resistant bacteria","volume":"36","author":"Dersch","year":"2015","journal-title":"Neurol. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1093\/jac\/dkv219","article-title":"Prevalence of MRSA and Gram-negative bacteria with ESBLs and carbapenemases in patients from Northern Africa at a German hospital","volume":"70","author":"Leistner","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_36","first-page":"26","article-title":"Meldepflicht f\u00fcr Carbapenem-resistente gramnegative Erreger: Eine Public Health-Priorit\u00e4t?","volume":"40","author":"Hauri","year":"2015","journal-title":"Hyg. Med."},{"key":"ref_37","first-page":"666","article-title":"Acinetobacter baumannii sepsis is fatal in medical intensive care unit patients: Six cases and review of literature","volume":"42","author":"Lahmer","year":"2014","journal-title":"Anaesth. Intensive Care"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1186\/1471-2334-14-446","article-title":"Burden of carbapenem-resistant organisms in the Frankfurt\/Main Metropolitan Area in Germany 2012\/2013\u2014First results and experiences after the introduction of legally mandated reporting","volume":"14","author":"Kleinkauf","year":"2014","journal-title":"BMC Infect. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/1469-0691.12026","article-title":"Molecular epidemiology of Acinetobacter baumannii and Acinetobacter nosocomialis in Germany over a 5-year period (2005-2009)","volume":"19","author":"Schleicher","year":"2013","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_40","first-page":"16","article-title":"Carbapenemasen bei Acinetobacter baumannii: Molekulare epidemiologie in Deutschland und Hinweise zur Diagnostik","volume":"37","author":"Kaase","year":"2012","journal-title":"Hyg. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00103-012-1552-x","article-title":"Carbapenemasen bei gramnegativen Erregern in Deutschland. Daten des Nationalen Referenzzentrums fur gramnegative Krankenhauserreger","volume":"55","author":"Kaase","year":"2012","journal-title":"Bundesgesundheitsblatt Gesundh. Gesundh."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1093\/jac\/dkr256","article-title":"Molecular characterization of blaNDM-1 in an Acinetobacter baumannii strain isolated in Germany in 2007","volume":"66","author":"Pfeifer","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s00105-010-1962-3","article-title":"Nekrotisierende Fasziitis durch Acinetobacter baumannii: Ein Fallbericht","volume":"62","author":"Wagner","year":"2011","journal-title":"Hautarzt"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1128\/AAC.00598-10","article-title":"In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient","volume":"54","author":"Higgins","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00404-009-1107-z","article-title":"Acinetobacter baumannii infection during pregnancy and puerperium","volume":"281","author":"Aivazova","year":"2010","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s15010-009-9225-x","article-title":"Increasing occurrence of multidrug-resistance in Acinetobacter baumannii isolates from four German University Hospitals, 2002\u20132006","volume":"38","author":"Wadl","year":"2010","journal-title":"Infection"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S1473-3099(10)70275-9","article-title":"Global spread of New Delhi metallo-beta-lactamase 1","volume":"10","author":"Gottig","year":"2010","journal-title":"Lancet. Infect. Dis."},{"key":"ref_48","first-page":"326","article-title":"Zum Auftreten multiresistenter NDM-1-carbapenemase bildender Escherichia coli und Acinetobacter baumannii in Deutschland","volume":"35","author":"Pfeifer","year":"2010","journal-title":"Hyg. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000220245","article-title":"A longitudinal analysis of antimicrobial susceptibility in clinical institutions in Germany as part of the Tigecycline Evaluation and Surveillance Trial (2004\u20132007)","volume":"55","author":"Seifert","year":"2009","journal-title":"Chemotherapy"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s10096-009-0725-5","article-title":"Susceptibility of clinical isolates of frequently encountered bacterial species to tigecycline one year after the introduction of this new class of antibiotics: Results of the second multicentre surveillance trial in Germany (G-TEST II, 2007)","volume":"28","author":"Kresken","year":"2009","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1469-0691.2007.01943.x","article-title":"Comparative analysis of antimicrobial susceptibility among organisms from France, Germany, Italy, Spain and the UK as part of the Tigecycline Evaluation and Surveillance Trial","volume":"14","author":"Rodloff","year":"2008","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ijheh.2006.05.004","article-title":"Fatal multidrug-resistant Acinetobacter baumannii sepsis in a patient with travel history and recent onset of systemic lupus erythematosus: A case report","volume":"209","author":"Weyrich","year":"2006","journal-title":"Int. J. Hyg. Environ. Health"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jhin.2005.05.009","article-title":"Clonal spread of meropenem-resistant Acinetobacter baumannii strains in hospitals in the Mediterranean region and transmission to South-West Germany","volume":"61","author":"Schulte","year":"2005","journal-title":"J. Hosp. Infect."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1469-0691.2004.01015.x","article-title":"Activities of various beta-lactams and beta-lactam\/beta-lactamase inhibitor combinations against Acinetobacter baumannii and Acinetobacter DNA group 3 strains","volume":"11","author":"Brauers","year":"2005","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/jac\/dkh427","article-title":"Selection of topoisomerase mutations and overexpression of adeB mRNA transcripts during an outbreak of Acinetobacter baumannii","volume":"54","author":"Higgins","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1046\/j.1469-0691.2003.00786.x","article-title":"Comparative in vitro activity of piperacillin, piperacillin-sulbactam and piperacillin-tazobactam against nosocomial pathogens isolated from intensive care patients","volume":"9","author":"Frank","year":"2003","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/PL00000303","article-title":"Pneumonia in multiple injured patients: A prospective controlled trial on early prediction using clinical and immunological parameters","volume":"51","author":"Andermahr","year":"2002","journal-title":"Inflamm. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1128\/AAC.44.8.2211-2213.2000","article-title":"Comparative activities of ciprofloxacin, clinafloxacin, gatifloxacin, gemifloxacin, levofloxacin, moxifloxacin and trovafloxacin against epidemiologically defined Acinetobacter baumannii strains","volume":"44","author":"Heinemann","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_59","unstructured":"Robert Koch Institiute (RKI) (2020, March 05). Infection epidemiological yearbook (2006\u20132018). Available online: https:\/\/www.rki.de\/DE\/Content\/Infekt\/Jahrbuch\/jahrbuch_node.html."},{"key":"ref_60","unstructured":"Robert Koch Institiute (RKI) (2020, March 05). Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten f\u00fcr 2018. Available online: https:\/\/www.rki.de\/DE\/Content\/Infekt\/Jahrbuch\/Jahrbuch_2018.pdf?__blob=publicationFile."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"R113","DOI":"10.1186\/cc9062","article-title":"Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: Secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008","volume":"14","author":"Meyer","year":"2010","journal-title":"Crit. Care Lond. Engl."},{"key":"ref_62","first-page":"P797","article-title":"Molecular characterisation and outbreak analysis of multidrug-resistant Acinetobacter baumannii from German hospitals","volume":"6","author":"Pfeifer","year":"2010","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.3201\/eid1709.101931","article-title":"Multidrug-resistant Acinetobacter baumannii in veterinary clinics, Germany","volume":"17","author":"Zordan","year":"2011","journal-title":"Emerg. Infect. Dis."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.3389\/fmicb.2017.01282","article-title":"Occurrence of the mcr-1 colistin resistance gene and other clinically relevant antibiotic resistance genes in microbial populations at different municipal wastewater treatment plants in Germany","volume":"8","author":"Hembach","year":"2017","journal-title":"Front. Microbiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.cmi.2017.11.020","article-title":"Antimicrobial susceptibility testing of colistin\u2014Evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter spp","volume":"24","author":"Matuschek","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_66","first-page":"345","article-title":"Treatment options for carbapenem-resistant Gram-negative infections","volume":"115","author":"Fritzenwanker","year":"2018","journal-title":"Dtsch. Arztebl. Int."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1086\/595977","article-title":"Nosocomial outbreak of infection with pan-drug-resistant Acinetobacter baumannii in a tertiary care university hospital","volume":"30","author":"Valencia","year":"2009","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3389\/fcimb.2017.00156","article-title":"Risk Factors, Clinical presentation and outcome of Acinetobacter baumannii bacteremia","volume":"7","author":"Ballouz","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11259-018-9742-0","article-title":"Acinetobacter baumannii\u2014A neglected pathogen in veterinary and environmental health in Germany","volume":"43","author":"Wareth","year":"2019","journal-title":"Vet. Res. Commun."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3389\/fmicb.2018.00536","article-title":"Diversity and antibiotic susceptibility of Acinetobacter strains from milk powder produced in Germany","volume":"9","author":"Cho","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1111\/1462-2920.13931","article-title":"Relatedness of wildlife and livestock avian isolates of the nosocomial pathogen Acinetobacter baumannii to lineages spread in hospitals worldwide","volume":"19","author":"Wilharm","year":"2017","journal-title":"Environ. Microbiol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3389\/fmicb.2019.00272","article-title":"Seasonal occurrence and carbapenem susceptibility of bovine Acinetobacter baumannii in Germany","volume":"10","author":"Klotz","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s10096-011-1415-7","article-title":"Evaluation of species-specific score cutoff values of routinely isolated clinically relevant bacteria using a direct smear preparation for matrix-assisted laser desorption\/ionization time-of-flight mass spectrometry-based bacterial identification","volume":"31","author":"Szabados","year":"2012","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/jam.13169","article-title":"Colistin and tigecycline resistance in carbapenemase-producing Gram-negative bacteria: Emerging resistance mechanisms and detection methods","volume":"121","author":"Govinden","year":"2016","journal-title":"J. Appl. Microbiol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1093\/jac\/dky289","article-title":"Peptidoglycan recycling contributes to intrinsic resistance to fosfomycin in Acinetobacter baumannii","volume":"73","author":"Costas","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_76","first-page":"858","article-title":"Surveillance of antibiotic use and resistance in intensive care units (SARI)","volume":"114","author":"Remschmidt","year":"2017","journal-title":"Dtsch. Arztebl. Int."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/jac\/36.3.585","article-title":"Transferable imipenem-resistance in Acinetobacter species from a clinical source","volume":"36","author":"Scaife","year":"1995","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.vetmic.2014.02.001","article-title":"An emerging public health problem: Acquired carbapenemase-producing microorganisms are present in food-producing animals, their environment, companion animals and wild birds","volume":"171","author":"Guerra","year":"2014","journal-title":"Vet. Microbiol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1093\/jac\/dkz360","article-title":"Molecular characterization of carbapenem-resistant Acinetobacter baumannii using WGS revealed missed transmission events in Germany from 2012-15","volume":"74","author":"Eigenbrod","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/cid\/civ225","article-title":"Fatal outbreak of an emerging clone of extensively drug-resistant Acinetobacter baumannii with enhanced virulence","volume":"61","author":"Jones","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/jac\/dkp428","article-title":"Global spread of carbapenem-resistant Acinetobacter baumannii","volume":"65","author":"Higgins","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1469-0691.2008.02010.x","article-title":"Molecular epidemiology of clinical Acinetobacter baumannii and Acinetobacter genomic species 13TU isolates using a multilocus sequencing typing scheme","volume":"14","author":"Wisplinghoff","year":"2008","journal-title":"Clin. Microbiol. Infect."}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/8\/3\/375\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:04:52Z","timestamp":1760173492000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/8\/3\/375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,6]]},"references-count":82,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3]]}},"alternative-id":["microorganisms8030375"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms8030375","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,6]]}}}